Virtual Trials Webinar

– On demand by filling out the form on the right

Patients have started to become reluctant to visit sites due to COVID-19, and studies must change to accommodate this. This development is pushing for a faster adaptation of virtual trials, either fully or partially.   

The webinar will focus on the advantages of virtual trials, and how virtual trials enable the study to get closer to the patients. We will go through the typical components in a virtual trial, both the internal processes, the services needed and the technology. 

Patient engagement, the devices used (incl. smartphone apps), eCOA/eDiary, eConsent and mobile data collection will be covered in the webinar. We will also go through the typical services needed to roll out to patients. Additionally, we’ll discuss strategies to avoid patient selection bias.

After the webinar you will know how to get started with the planning of virtual trials.

    You must agree before submitting.

    For more information on how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

    Input this code: captcha

    Subscribe to our newsletter or explore our webinars.


    John Aggerholm

    John Aggerholm

    Project Director

    John is a life sciences industry veteran, with over 30 years of experience working in the pharmaceutical world. Working as a Project Director, his experience includes multiple clinical systems analysis and implementation projects. Recently, John has focused on Virtual Trials and has helped multiple of our pharmaceutical clients develop and implement Decentralized Trial Frameworks.